AgingResearch.NewsJoin free

CD38+HLA-DR+ T-cell activation

There is 1 paper on CD38+HLA-DR+ T-cell activation in aging research: 1 observational study in people. The newest story, Nov 2, 2026: “HIV drug switch linked to fewer signs of immune-cell aging”.

Biomarker

1 paper studies it1 finding

See all 1 papers on CD38+HLA-DR+ T-cell activation

“When comparing the patients with osteopenia/osteoporosis with those with a normal BMD, no differences in activation and senescence were found.”
Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patientsThe Netherlands journal of medicine2017
  • Humans1

Effects

1

Osteopenia/osteoporosis

no changein humans1

1 study

  1. CD38+HLA-DR+ T-cell activation was not clearly linked with osteopenia/osteoporosis in humans (cART-treated HIV-infected patients).

    “When comparing the patients with osteopenia/osteoporosis with those with a normal BMD, no differences in activation and senescence were found.”

    HumanscART-treated HIV-infected patientsmalesn = 16

    Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients

    The Netherlands journal of medicine

More on Osteopenia/osteoporosis

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Immunology

HIV drug switch linked to fewer signs of immune-cell aging

Over 48 weeks, 37 adults switching to injectable HIV drugs had larger declines in immune-cell activation and aging markers than nine continuing oral drugs.Over 48 weeks, 37 adults switching to injectable HIV drugs had larger declines in immune-cell activation and aging markers than nine continuing oral drugs.

Cohort studyBlood and immune system
Paper

Related